Stock SBFM SUNSHINE BIOPHARMA, INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Sunshine Biopharma, Inc.

Equities

SBFM

US8677816014

End-of-day quote Nasdaq
Other stock markets
 06:00:00 2024-04-23 pm EDT 		5-day change 1st Jan Change
0.93 USD -23.14% Intraday chart for Sunshine Biopharma, Inc. -75.53% -96.57%
Apr. 19 Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product MT
Apr. 19 Top Premarket Decliners MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Sunshine Biopharma's Nora Pharma Receives Health Canada Approval for Niopeg, a Biosimilar of Neulasta
AQ
Sunshine Biopharma Unit Receives Health Canada Approval for Biosimilar Product
MT
Top Premarket Decliners
MT
Sunshine Biopharma Announces Reverse Stock Split
AQ
Sunshine Biopharma Shares Slump After Reverse Stock Split Announcement
MT
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.
CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Sunshine Biopharma, Inc. announced that it has received $5 million in funding
CI
Thinking about buying stock in Mediwound, AeroVironment, Airship AI, Lyell Immunopharma, or Sunshine Biopharma?
PR
Sunshine Biopharma, Inc. announced that it expects to receive $0.01 million in funding
CI
Sunshine Biopharma, Inc. Announces Executive Changes
CI
Sunshine Biopharma Moves Principal Office to New York City
AQ
Sunshine Biopharma, Inc. Announces Move Its Headquarters to New York City
CI
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.
CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Jewish General Hospital Announces Termination of the Research Agreement with Sunshine Biopharma, Inc
CI
Sunshine Biopharma Gets Extension to Comply With Nasdaq Minimum Bid Price Rule
MT
Sunshine Biopharma Reports 2023 Second Quarter Results: Revenues Up 3,600%
AQ
Tranche Update on Sunshine Biopharma, Inc.'s Equity Buyback Plan announced on January 19, 2023.
CI
Sunshine Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. SBFM Stock
  4. News Sunshine Biopharma, Inc.